查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439250

結構性心臟病設備 - 全球市場回顧、競爭格局、市場預測（2030 年）

Structural Heart Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計2023年全球結構性心臟病器材市場規模為98.1億美元，2030年將達186.7億美元，預計2024-2030年期間複合年增長率為11.33%。對結構性心臟病設備的需求主要是由於結構性心臟病患病率的迅速上升、微創幹預措施的日益普及、產品開發中研發活動的增加以及新的和先進產品的批准而推動的。各種報銷和保險計劃中的結構性心臟病設備。

心臟結構器材市場動態

根據2020 年發表在《Lancet》的《 "Global, regional, and national burden of congenital heart disease, 1990-2017：a systematic analysis for the Global Burden of Disease Study 2017》，2017年全球先天性心臟病導致261,247人死亡，其中180,624人是嬰兒。儘管由於社會人口指標的增加，與先心病相關的死亡率多年來一直在下降，但先天性疾病的盛行率多年來卻在增加，2017年有11,998,283人患有先天性疾病。

根據British Heart Foundation的一份情況說明書，到2022年，英國出生的嬰兒中約有五分之一將被診斷出患有心臟異常，這意味著英國平均每天約有13名嬰兒被診斷出患有心臟異常。這會導致在以後的生活中做出更多的診斷。據估計，1-2% 的英國人口可能受到冠心病的影響。

Grave 等人於 2020 年在《Journal of the American Heart Association》上發表了 "Epidemiological Features of Aortic Stenosis in a French Nationwide Study: 10-Year Trends and New Challenges" ，主動脈瓣狹窄 (AS) 是歐洲最常見的心臟瓣膜疾病，也是美國第二大常見疾病。主動脈瓣狹窄的盛行率隨著年齡的增長而呈指數級增長，據估計，在美國65 歲以下人口中，主動脈瓣狹窄的盛行率為0.2%，在75 歲以上人口中，這一比例為2.8%。

此外，經導管修復和置換等微創手術在結構性心臟病治療中的日益普及，也為結構性心臟病器械市場的成長帶來了重要前景。

然而，產品召回的數量和嚴格的產品審批監管標準可能會限制預測期內結構性心臟病設備市場的成長。

結構性心臟病設備市場細分分析

在結構性心臟病設備市場的產品領域，與替代設備相比，恢復設備類別預計將佔據更大的市場份額。這是因為外科醫生更傾向於將修復而不是替換作為首選。這是因為在心臟結構缺陷的治療中，修復手術往往可以保留心肌的強度和功能，減少術後感染（如心內膜炎）的機會，並且因為置換手術有多種優點。修復程序，包括與設備相比更好的預後以及相對較少的對血液稀釋劑的依賴。

在修復手術類別中，瓣膜成形術設備由於其在瓣膜修復手術，尤其是二尖瓣修復手術中的重要性，預計將獲得顯著的市場份額。瓣膜成形術環被認為是必不可少的，因為它們有助於恢復瓣膜的自然瓣環形狀和尺寸，防止未來瓣環擴張，並為瓣環提供功能支撐。此外，這些設備可以靈活地應用於心臟直視手術或微創手術。

該報告提供了全球結構性心臟病設備市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第1章 結構性心臟病設備市場報告簡介

第2章 結構性心臟病設備市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估
  • 財務基準

第3章 法規與專利分析

  • 美國
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
  • 日本

第4章 結構性心臟病器材市場的主要驅動因素分析

  • 結構性心臟病設備市場的驅動因素
    • 結構性心臟病盛行率上升
    • 微創手術需求不斷成長
    • 技術進步促進新產品開發
    • 將結構性心臟病裝置納入各種報銷和保險計劃
  • 結構性心臟病器材市場的限制與挑戰
    • 頻繁的產品故障和召回
    • 嚴格的產品審批流程
  • 結構性心臟病設備市場的機遇
    • 推出針對新興市場的產品
    • 提高產品安全性

第5章 結構性心臟病器材市場的波特五力分析

第6章 COVID-19對結構性心臟病器材市場的影響分析

第7章 結構性心臟病器材市場佈局

  • 按產品類型
    • 修復手術裝置
    • 更換裝置
  • 按用途
    • 房間隔缺損
    • 主動脈瓣狹窄
    • 卵圓孔未閉
    • 室間隔缺損
    • 二尖瓣關閉不全
    • 其他
  • 按最終用戶
    • 醫院
    • 門診手術中心
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 結構性心臟病器材市場：全球公司份額分析－3至5家主要公司

第9章 結構性心臟病設備市場公司與產品概況

  • Medtronic
  • Boston Scientific Corporation
  • Braile Biomedica
  • Edwards Life Sciences Corporation
  • Valcare Medical
  • W. L. Gore & Associates Inc
  • Abbott
  • XELTIS BV
  • JenaValve Technology, Inc
  • Lepu Medical Technology (Beijing) Co. Ltd
  • Livanova plc
  • Comed BV
  • TORAY INDUSTRIES INC
  • Occlutech International AB
  • Microport Scientific Corporation

第10章 項目方法

  • 二次資料
  • 一次資料
  • 數據三角測量
  • 主要專家意見

第11章 KOL觀點

第12章 DelveInsight服務內容

第13章 免責聲明

第14章 關於 DelveInsight

Product Code: DIMDCL0037

Structural Heart Devices Market By Product Type (Repair Devices [Occluders, Annuloplasty Devices, Valvuloplasty Devices, Others] And Replacement Devices [Mechanical Heart Valves And Tissue Heart Valves]), By Application (Atrial Spetal Defect, Aortic Valve Stenosis, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Regurgitation, And Others) And By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of structural heart diseases and the development of new products.

Global Structural Heart Devices Market was valued at USD 9.81 billion in 2023, growing at a CAGR of 11.33% during the forecast period from 2024 to 2030 to reach USD 18.67 billion by 2030. The demand for structural heart devices is primarily being boosted by the rapid growth in the prevalence of structural heart diseases, growing popularity of minimally invasive interventions, increase in the research and development activities in product development, the approval of new and advanced products, and the inclusion of structural heart devices in various reimbursement & insurance programs.

Structural Heart Devices Market Dynamics:

As per the Global Burden of Diseases Study published in the Lancet journal in 2020, titled "Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017", congenital heart disease caused 261,247 deaths across the globe in 2017, of which 180,624 were infants. Even though the mortality rates associated with CHD have decreased over the years due to increasing socio-demographic index, the prevalence of congenital diseases have witnessed an increase over the years with 11,998,283 people living with it in 2017.

According to the factsheet by the British Heart Foundation, 2022, about one in 50 births are diagnosed with heart defects in the UK, which averages to about 13 babies each day in the UK with more diagnoses later in life. Estimates suggest that in total as many as 1-2 per cent of the population in the country may be affected with CHD.

As per the study published in the Journal of the American Heart Association by Grave et al in 2020 titled "Epidemiological Features of Aortic Stenosis in a French Nationwide Study: 10-Year Trends and New Challenges", aortic stenosis (AS) is the most common form of valvular heart disease in Europe, and the second most common indication in the United States. The prevalence of aortic stenosis is estimated to increase exponentially with age and has been estimated at 0.2% of the US population before the age of 65 years and 2.8% after the age of 75 years.

Moreover, the rising popularity of minimally invasive procedures such as transcatheter repair and replacement techniques in treating structural heart diseases, have further provided great landscape for the structural heart devices market growth.

However, the number of product recalls and rigid regulatory norms for product approval may restrain the growth of the structural heart devices market during the forecast period.

Structural Heart Devices Market Segment Analysis:

Structural Heart Devices market by Product Type (Repair Devices [Occluders, Annuloplasty Devices, Valvuloplasty Devices, Others] and Replacement Devices [Mechanical Heart Valves And Tissue Heart Valves]), Structural Heart Devices market by Application (Atrial Septal Defect, Aortic Valve Stenosis, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Regurgitation, And Others) Structural Heart Devices market by End User (Hospitals, Ambulatory Surgical Centers, And Others), and Structural Heart Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In product segment of the structural heart devices market, the repair devices category is expected to account for the larger market share compared to the replacement devices. This can be attributed to the preference of surgeons to repair procedures over replacement ones as the first choice. These is due to the several benefits associated with the repair procedures in treating structural heart defects such as repairing strategies tend to preserve the strength, and function of the heart muscle, reduces the chances of post-surgery infections such as endocarditis, offers better prognosis compared to replacement devices, and comparatively less dependency on blood-thinners.

In the repair category, annuloplasty devices are expected to amass significant market share due to their significant importance in valve repair, specifically the mitral valve. An annuloplasty ring is considered essential as it helps in restoring the shape and the size of the native annulus of the valve, it prevents future dilation of the annulus, and offers functional support to the annulus. Furthermore, these devices offer the flexibility to be administered as a treatment both via an open heart surgery or minimally invasive approach.

In October 2020, Genesee BioMedical Inc received the FDA approval for their TruForm Sievers Annuloplasty Ring, Model TRH for the treatment of the correction of mitral valvular insufficiency where the lesions are not so severe as to require total valve replacement.

However, the rising popularity of minimally invasive interventions such as transcatheter-based approaches for valve repair such as Edwards Cardioband Mitral Reconstruction System, MitraClip and Carillon Mitral Contour System are expected to witness a faster growth in demand in the forecast period.

North America is expected to dominate the Overall Strucutral Heart Devices Market:

Among all the regions, North America is expected to amass the largest share in the structural heart devices market. The growing prevalence of structural heart disease, better healthcare facilities coupled with the presence of major market players as well as supportive reimbursement programs in the region are predicted to be the major influencing factors in driving the overall growth of the structural heart devices market over the forecast period.

In North America, the US is expected to account for the largest share of the North American Structural Heart Devices market. This can be attributed to the increasing cases of structural heart diseases. According to the Centers for Disease Control and Prevention (CDC) data (2023), congenital heart diseases affect approximately 40,000 births per year in the country. It has been estimated that about one in 4 babies suffer from a critical form of CHD. The commonest type of heart defect is the ventricular septal defect.

As per the data provided by the CDC (2023), near about 2.5% of the US population suffers from valvular heart disease and it is more commonly observed in the older population.

Aortic stenosis is one of the commonest and serious valve disease problems and is one of the type of valvular heart diseases. The aortic valve opening becomes narrow in this indication which results in the restricted blood flow from the left ventricle to the aorta. As per the factsheet provided by the American Heart Association (2023), about 20% of the people in the United States over the age of 65 suffer from aortic stenosis.

Moreover, the large presence of key market players namely Abbott, Edwards Lifesciences Corporation, Livanova plc in the country as well as the launch of new products in the country also provide favorable conditions for the growth of the structural heart devices market.

In September 2020, the US Food and Drug Administration expanded the product approval for the The SAPIEN 3 and SAPIEN 3 Ultra THV System by Edwards Lifesciences Corporation to include the replacement of a failing (narrowed, leaky, or both) use previously implanted transcatheter aortic valve. The device has been previously approved to be used in the treatment of aortic stenosis as well as a replacement for the replacement of a failing (narrowed, leaky, or both) previously implanted surgical artificial aortic or mitral heart valve in patients who are too high risk for open-heart surgery. Such frequent revisions of the device applications and safety assessment by the country's regulatory authorities also play a key role in instilling faith in device manufacturers and end users.

Therefore, the market for structural heart devices in the United States and North America is predicted to witness significant growth in the forecast period.

Structural Heart Devices Market Key Players:

Some of the key market players operating in the structural heart devices market includes Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc, Biomerics, Lepu Medical Technology (Beijing) Co. Ltd, Livanova plc, Comed B.V., TORAY INDUSTRIES INC, Occlutech International AB, Microport Scientific Corporation and others.

Recent Developmental Activities in Structural Heart Devices Market:

In August 2022, Medtronic received the 510k clearance from the US Food and Drug Administration for their new-generation, self-expanding transcatheter aortic valve replacement (TAVR) system- Evolut FX TAVR system. This device is aimed at treating patients with symptomatic severe aortic stenosis while maintaining the feautres offered by their Evolut platform such as hemodynamics and durability.

In August 2022, Occlutech Holding AG was granted an Investigational Device Exemption (IDE) by the US FDA for their Flex II PFO Occluder. This IDE would allow the company to conduct a clinical study to gather safety and efficacy data for their device to support their premarket approval in order to access the US markets.

In March 2022, Medtronic received the 510k approval by the US FDA for their Harmony Transcatheter Pulmonary Valve System. This system is the first-ever non-surgical valve replacement device in the world for the treatment of certain types of congenital heart disease in both adult and pediatric populations.

Key Takeaways from the Structural Heart Devices Market Report Study

Market size analysis for current structural heart devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the structural heart devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global structural heart devices market.

Various opportunities available for the other competitor in the structural heart devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030?

Which is the top-performing regions and countries in the current structural heart devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for structural heart devices market growth in the coming future?

Target Audience who can be benefited from this Structural Heart Devices Market Report Study

Structural Heart Devices products providers

Research organizations and consulting companies

Structural Heart Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in structural heart devices

Various End-users who want to know more about the structural heart devices market and latest technological developments in the structural heart devices market.

Frequently Asked Questions for Structural Heart Devices Market:

1. What is are Structural Heart Devices?

Structural heart devices are various types of devices that are used in the treatment of structural heart defects. Depending upon the degree of the defect, different types of structural heart devices can be employed either in the repair of the defect or replacement, such as replacement of a heart valve.

2. What is the market for Global Structural Heart Devices?

Global Structural Heart Devices Market was valued at USD 8.82 billion in 2023, growing at a CAGR of 11.33% during the forecast period from 2024 to 2030 to reach USD 18.67 billion by 2030.

3. What are the drivers for Global Structural Heart Devices Market?

The major factors boosting the demand for Structural Heart Devices in the market the rising prevalence of structural heart diseases, increasing popularity of minimally invasive interventions, and favourable reimbursement programs related to these procedures.

4. What are the key players operating in Global Structural Heart Devices?

Some of the important market players operating in the the structural heart devices market includes Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc, Biomerics, Lepu Medical Technology (Beijing) Co. Ltd, Livanova plc, Comed B.V., TORAY INDUSTRIES INC, Occlutech International AB, Microport Scientific Corporation and others.

5. What region has the highest share in Structural Heart Devices market?

North America is projected to dominate the structural heart devices market in terms of revenue in the during the forecast period. This can be related to the high number of cases of structural heart diseases, better healthcare system, and presence of major market players in the region, primarily in the US.

Table of Contents

1.Structural Heart Devices Market Report Introduction

2.Structural Heart Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
    • 3.2.1. Germany
    • 3.2.2. France
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. U.K.
  • 3.3. Japan

4. Structural Heart Devices Market Key Factors Analysis

  • 4.1. Structural Heart Devices Market Drivers
    • 4.1.1. Rising Prevalence of Structural Heart Diseases
    • 4.1.2. Growing demand for Minimally-Invasive Procedures
    • 4.1.3. Technological Advancements Leading to New Product Development
    • 4.1.4. Inclusion of Structural Heart Devices In Various Reimbursement & Insurance Programs
  • 4.2. Structural Heart Devices Market Restraints and Challenges
    • 4.2.1. Frequent Product Failures and Recalls
    • 4.2.2. Stringent Product Approval Process
  • 4.3. Structural Heart Devices Market Opportunities
    • 4.3.1. Targeting Emerging Markets for Product Launches
    • 4.3.2. Product Improvement in Terms of Safety

5. Structural Heart Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Structural Heart Devices Market

7. Structural Heart Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Repair Devices
      • 7.1.1.1. Occluders
      • 7.1.1.2. Annuloplasty Devices
      • 7.1.1.3. Valvuloplasty Devices
      • 7.1.1.4. Others
    • 7.1.2. Replacement Devices
      • 7.1.2.1. Mechanical Valves
      • 7.1.2.2. Tissue Valves
  • 7.2. By Application
    • 7.2.1. Atrial Septal Defects
    • 7.2.2. Aortic Valve Stenosis
    • 7.2.3. Patent Foramen Ovale
    • 7.2.4. Ventricular Septal Defects
    • 7.2.5. Mitral Valve Regurgitation
    • 7.2.6. Others
  • 7.3. By End User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Structural Heart Devices Market, by Product Type
      • 7.4.1.2. North America Structural Heart Devices Market, by Application
      • 7.4.1.2. North America Structural Heart Devices Market, by End User
      • 7.4.1.4. North America Structural Heart Devices Market, by Country
      • 7.4.1.1.1. United States
      • 7.4.1.1.2. Canada
      • 7.4.1.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Structural Heart Devices Market, by Product Type
      • 7.4.2.2. Europe Structural Heart Devices Market, by Application
      • 7.4.2.3. Europe Structural Heart Devices Market, by End User
      • 7.4.2.4. Europe Structural Heart Devices Market, by Country
      • 7.4.2.2.1. France
      • 7.4.2.2.2. Germany
      • 7.4.2.2.3. United Kingdom
      • 7.4.2.2.4. Italy
      • 7.4.2.2.5. Spain
      • 7.4.2.2.6. Russia
      • 7.4.2.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Structural Heart Devices Market, by Product Type
      • 7.4.3.2. Asia-Pacific Structural Heart Devices Market, by Application
      • 7.4.3.3. Asia-Pacific Structural Heart Devices Market, by End User
      • 7.4.3.4. Asia-Pacific Structural Heart Devices Market, by Country
      • 7.4.3.4.1. China
      • 7.4.3.4.2. Japan
      • 7.4.3.4.3. India
      • 7.4.3.4.4. Australia
      • 7.4.3.4.5. South Korea
      • 7.4.3.4.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW Structural Heart Devices Market, by Product Type
      • 7.4.4.2. RoW Structural Heart Devices Market, by Application
      • 7.4.4.3. RoW Structural Heart Devices Market, by End User
      • 7.4.4.4. RoW Structural Heart Devices Market, by Country
      • 7.4.4.3.1. Middle East
      • 7.4.4.3.2. Africa
      • 7.4.4.3.3. South America

8. Structural Heart Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Structural Heart Devices Market Company and Product Profiles

  • 9.1. Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Boston Scientific Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Braile Biomedica
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Edwards Life Sciences Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Valcare Medical
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. W. L. Gore & Associates Inc
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Abbott
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. XELTIS BV
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. JenaValve Technology, Inc
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Lepu Medical Technology (Beijing) Co. Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Livanova plc
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Comed BV
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. TORAY INDUSTRIES INC
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Occlutech International AB
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Microport Scientific Corporation
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy

10. Project Approach

  • 10.1. Secondary Sources
  • 10.2. Primary Sources
  • 10.3. Data Triangulation
  • 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Structural Heart Devices Market
  • Table 3: Structural Heart Devices Market in Global (2021-2030)
  • Table 4: Structural Heart Devices Market in Global by Product Type (2021-2030)
  • Table 5: Structural Heart Devices Market in Global by Application (2021-2030)
  • Table 6: Structural Heart Devices Market in Global by End User (2021-2030)
  • Table 7: Structural Heart Devices Market in Global by Geography (2021-2030)
  • Table 8: Structural Heart Devices Market in North America (2021-2030)
  • Table 9: Structural Heart Devices Market in North America by Product Type (2021-2030)
  • Table 10: Structural Heart Devices Market in North America by Application (2021-2030)
  • Table 11: Structural Heart Devices Market in North America by End User (2021-2030)
  • Table 12: Structural Heart Devices Market in North America by Country (2021-2030)
  • Table 13: Structural Heart Devices Market in the US (2021-2030)
  • Table 14: Structural Heart Devices Market in Canada (2021-2030)
  • Table 15: Structural Heart Devices Market in Mexico (2021-2030)
  • Table 16: Structural Heart Devices Market in Europe (2021-2030)
  • Table 17: Structural Heart Devices Market in Europe by Product Type (2021-2030)
  • Table 18: Structural Heart Devices Market in Europe by Application (2021-2030)
  • Table 19: Structural Heart Devices Market in Europe by End User (2021-2030)
  • Table 20: Structural Heart Devices Market in Europe by Country (2021-2030)
  • Table 21: Structural Heart Devices Market in France (2021-2030)
  • Table 22: Structural Heart Devices Market in Germany (2021-2030)
  • Table 23: Structural Heart Devices Market in the United Kingdom (2021-2030)
  • Table 24: Structural Heart Devices Market in Italy (2021-2030)
  • Table 25: Structural Heart Devices Market in Spain (2021-2030)
  • Table 26: Structural Heart Devices Market in Russia (2021-2030)
  • Table 27: Structural Heart Devices Market in Rest of Europe (2021-2030)
  • Table 28: Structural Heart Devices Market in APAC (2021-2030)
  • Table 29: Structural Heart Devices Market in APAC by Product Type (2021-2030)
  • Table 30: Structural Heart Devices Market in APAC by Application (2021-2030)
  • Table 31: Structural Heart Devices Market in APAC by End User (2021-2030)
  • Table 32: Structural Heart Devices Market in APAC by Country (2021-2030)
  • Table 33: Structural Heart Devices Market in China (2021-2030)
  • Table 34: Structural Heart Devices Market in Japan (2021-2030)
  • Table 35: Structural Heart Devices Market in India (2021-2030)
  • Table 36: Structural Heart Devices Market in Australia (2021-2030)
  • Table 37: Structural Heart Devices Market in South Korea (2021-2030)
  • Table 38: Structural Heart Devices Market in Rest of APAC (2021-2030)
  • Table 39: Structural Heart Devices Market in Rest of World (2021-2030)
  • Table 40: Structural Heart Devices Market in RoW by Product Type (2021-2030)
  • Table 41: Structural Heart Devices Market in RoW by Application (2021-2030)
  • Table 42: Structural Heart Devices Market in RoW by End User (2021-2030)
  • Table 43: Structural Heart Devices Market in RoW by Region (2021-2030)
  • Table 44: Structural Heart Devices Market in Middle East (2021-2030)
  • Table 45: Structural Heart Devices Market in Africa (2021-2030)
  • Table 46: Structural Heart Devices Market in South America (2021-2030)

List of Figures

Figures 1: Competitive Analysis

Figures 2: COVID-19 Impact Analysis on Structural Heart Devices Market

Figures 3: Structural Heart Devices Market in Global (2021-2030)

Figures 4: Structural Heart Devices Market in Global by Product Type (2021-2030)

Figures 5: Structural Heart Devices Market in Global by Application (2021-2030)

Figures 6: Structural Heart Devices Market in Global by End User (2021-2030)

Figures 7: Structural Heart Devices Market in Global by Geography (2021-2030)

Figures 8: Structural Heart Devices Market in North America (2021-2030)

Figures 9: Structural Heart Devices Market in North America by Product Type (2021-2030)

Figures 10: Structural Heart Devices Market in North America by Application (2021-2030)

Figures 11: Structural Heart Devices Market in North America by End User (2021-2030)

Figures 12: Structural Heart Devices Market in North America by Country (2021-2030)

Figures 13: Structural Heart Devices Market in the US (2021-2030)

Figures 14: Structural Heart Devices Market in Canada (2021-2030)

Figures 15: Structural Heart Devices Market in Mexico (2021-2030)

Figures 16: Structural Heart Devices Market in Europe (2021-2030)

Figures 17: Structural Heart Devices Market in Europe by Product Type (2021-2030)

Figures 18: Structural Heart Devices Market in Europe by Application (2021-2030)

Figures 19: Structural Heart Devices Market in Europe by End User (2021-2030)

Figures 20: Structural Heart Devices Market in Europe by Country (2021-2030)

Figures 21: Structural Heart Devices Market in France (2021-2030)

Figures 22: Structural Heart Devices Market in Germany (2021-2030)

Figures 23: Structural Heart Devices Market in the United Kingdom (2021-2030)

Figures 24: Structural Heart Devices Market in Italy (2021-2030)

Figures 25: Structural Heart Devices Market in Spain (2021-2030)

Figures 26: Structural Heart Devices Market in Russia (2021-2030)

Figures 27: Structural Heart Devices Market in Rest of Europe (2021-2030)

Figures 28: Structural Heart Devices Market in APAC (2021-2030)

Figures 29: Structural Heart Devices Market in APAC by Product Type (2021-2030)

Figures 30: Structural Heart Devices Market in APAC by Application (2021-2030)

Figures 31: Structural Heart Devices Market in APAC by End User (2021-2030)

Figures 32: Structural Heart Devices Market in APAC by Country (2021-2030)

Figures 33: Structural Heart Devices Market in China (2021-2030)

Figures 34: Structural Heart Devices Market in Japan (2021-2030)

Figures 35: Structural Heart Devices Market in India (2021-2030)

Figures 36: Structural Heart Devices Market in Australia (2021-2030)

Figures 37: Structural Heart Devices Market in South Korea (2021-2030)

Figures 38: Structural Heart Devices Market in Rest of APAC (2021-2030)

Figures 39: Structural Heart Devices Market in Rest of World (2021-2030)

Figures 40: Structural Heart Devices Market in RoW by Product Type (2021-2030)

Figures 41: Structural Heart Devices Market in RoW by Application (2021-2030)

Figures 42: Structural Heart Devices Market in RoW by End User (2021-2030)

Figures 43: Structural Heart Devices Market in RoW by Region (2021-2030)

Figures 44: Structural Heart Devices Market in Middle East (2021-2030)

Figures 45: Structural Heart Devices Market in Africa (2021-2030)

Figures 46: Structural Heart Devices Market in South America (2021-2030)

Figures 47: Market Drivers

Figures 48: Market Barriers

Figures 49: Marker Opportunities

Figures 50: PORTER'S Five Force Analysis